The Medical Center has announced the appointment of Joanna Groden, PhD, as vice dean for Research for the OSU College of Medicine. Groden succeeds Clay Marsh, who has been named vice dean for Innovation for the College.
Groden, a nationally renowned authority on inherited cancers, has been a distinguished member of the Molecular Virology, Immunology and Medical Genetics faculty since 2005 and has served as the College of Medicine’s associate dean for Basic Science Research from 2007 until 2011 and associate dean for Graduate Studies since August 2011. She also co-directs our Biomedical Sciences Graduate Program and the Howard Hughes Medical Institute (HHMI) Med Into Grad Scholars Program.
Groden received her undergraduate degree in biology at Middlebury College, her PhD in cell biology and genetics at the Cornell University Graduate, School of Medical Sciences in New York City and completed a postdoctoral fellowship in the Department of Human Genetics/Howard Hughes Medical Institute at the University of Utah. She served on the Molecular Genetics, Biochemistry and Microbiology faculties of the University of Cincinnati College of Medicine from 1993 to 2005 and, during her last two years there, was the college’s vice dean for research. She was also an Investigator with the Howard Hughes Medical Institute from 1997-2004.
Groden is a fellow of the American Association for the Advancement of Science, a fellow of the American Gastroenterological Association and a widely sought lecturer nationally. She has mentored more than 30 pre- and postdoctoral trainees, received the University of Cincinnati Faculty Achievement Award in 1996, the OSU Human Cancer Genetics Program Commemorative Medal in 2001, and the OSU Excellence in Teaching Award in 2012.
Her research has been continuously funded by the National Institutes of Health/National Cancer Institute since 1994 and she is currently the principal investigator on an NIH/NCI R01 grant. She has served as chair of the Cancer Genetics Study Section of the NCI, and currently serves as a member of the Center for Scientific Review’s College of Reviewers and the Board of Scientific Counselors for NCI. Groden holds three patents, is a member of the editorial boards of the journals Molecular Carcinogenesis and Frontiers in Genetics, and has served on scientific review panels for research grant programs administered by the European Commission, Canada, Israel, Italy, Luxembourg and the United Kingdom.